Matrix gla protein gene polymorphism is associated with increased coronary artery calcification progression

Arteriosclerosis, Thrombosis, and Vascular Biology

Volumn 33, Issue 3, 2013, Pages 645-651

  Cassidy Bushrow, Andrea E ^a   Bielak, Lawrence F ^b   Levin, Albert M ^a   Sheedy, Patrick F ^c   Turner, Stephen T ^d   Boerwinkle, Eric ^e   Lin, Xihong ^f   Kardia, Sharon L R ^b   Peyser, Patricia A ^b  

^a HENRY FORD HOSPITAL   (United States)

^b UNIVERSITY OF MICHIGAN   (United States)

^c Division of Hypertension   (United States)

^d MAYO CLINIC   (United States)

^e UNIVERSITY OF TEXAS   (United States)

^f HARVARD UNIVERSITY   (United States)

Author keywords

atherosclerosis; calcium; genetics; imaging; population

Indexed keywords

ALANINE; MATRIX GLA PROTEIN; PROTEIN; THREONINE; UNCLASSIFIED DRUG;

ADULT; ARTICLE; CARDIOVASCULAR RISK; CORONARY ARTERY ATHEROSCLEROSIS; CORONARY ARTERY CALCIFICATION; DISEASE ASSOCIATION; DISEASE COURSE; FEMALE; GENE FREQUENCY; GENE REPLICATION; GENOTYPE; HEART INFARCTION; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; SINGLE NUCLEOTIDE POLYMORPHISM;

ADULT; AMINO ACID SUBSTITUTION; CALCIUM-BINDING PROTEINS; CHI-SQUARE DISTRIBUTION; CORONARY ANGIOGRAPHY; CORONARY ARTERY DISEASE; DISEASE PROGRESSION; EXTRACELLULAR MATRIX PROTEINS; FEMALE; GENE FREQUENCY; GENETIC PREDISPOSITION TO DISEASE; HUMANS; LINEAR MODELS; MALE; MIDDLE AGED; MINNESOTA; MYOCARDIAL INFARCTION; PHENOTYPE; POLYMORPHISM, SINGLE NUCLEOTIDE; PREVALENCE; RISK FACTORS; TIME FACTORS; TOMOGRAPHY, X-RAY COMPUTED; VASCULAR CALCIFICATION;

EID: 84874346496     PISSN: 10795642     EISSN: 15244636     Source Type: Journal    
DOI: 10.1161/ATVBAHA.112.300491     Document Type: Article

References (55)

1. Luo G, Ducy P, McKee MD, Pinero GJ, Loyer E, Behringer RR, Karsenty G. Spontaneous calcification of arteries and cartilage in mice lacking matrix GLA protein. Nature. 1997;386:78-81.
2. Online Mendelian Inheritance in Man, OMIM. Johns Hopkins University, Baltimore, MD. MIM Number: 245150: Date last edited: 06/09/2010. http://omim.org/. Accessed September 13, 2011.
3. Munroe PB, Olgunturk RO, Fryns JP, Van Maldergem L, Ziereisen F, Yuksel B, Gardiner RM, Chung E. Mutations in the gene encoding the human matrix Gla protein cause Keutel syndrome. Nat Genet. 1999;21:142-144.
4. Maher JE, Bielak LF, Raz JA, Sheedy PF II, Schwartz RS, Peyser PA. Progression of coronary artery calcification: a pilot study. Mayo Clin Proc. 1999;74:347-355.
5. Raggi P, Callister TQ, Shaw LJ. Progression of coronary artery calcium and risk of first myocardial infarction in patients receiving cholesterollowering therapy. Arterioscler Thromb Vasc Biol. 2004;24:1272-1277.
6. Raggi P, Cooil B, Shaw LJ, Aboulhson J, Takasu J, Budoff M, Callister TQ. Progression of coronary calcium on serial electron beam tomographic scanning is greater in patients with future myocardial infarction. Am J Cardiol. 2003;92:827-829.
7. Peyser PA, Bielak LF, Chu JS, Turner ST, Ellsworth DL, Boerwinkle E, Sheedy PF II. Heritability of coronary artery calcium quantity measured by electron beam computed tomography in asymptomatic adults. Circulation. 2002;106:304-308.
8. Cassidy-Bushrow AE, Bielak LF, Sheedy PF II, Turner ST, Kullo IJ, Lin X, Peyser PA. Coronary artery calcification progression is heritable. Circulation. 2007;116:25-31.
9. Jono S, Ikari Y, Vermeer C, Dissel P, Hasegawa K, Shioi A, Taniwaki H, Kizu A, Nishizawa Y, Saito S. Matrix Gla protein is associated with coronary artery calcification as assessed by electron-beam computed tomography. Thromb Haemost. 2004;91:790-794.
10. Crosier MD, Booth SL, Peter I, Dawson-Hughes B, Price PA, O'Donnell CJ, Hoffmann U, Williamson MK, Ordovas JM. Matrix Gla protein polymorphisms are associated with coronary artery calcification in men. J Nutr Sci Vitaminol. 2009;55:59-65.
11. O'Donnell CJ, Shea MK, Price PA, Gagnon DR, Wilson PW, Larson MG, Kiel DP, Hoffmann U, Ferencik M, Clouse ME, Williamson MK, Cupples LA, Dawson-Hughes B, Booth SL. Matrix Gla protein is associated with risk factors for atherosclerosis but not with coronary artery calcification. Arterioscler Thromb Vasc Biol. 2006;26:2769-2774.
12. Farzaneh-Far A, Davies JD, Braam LA, Spronk HM, Proudfoot D, Chan SW, O'Shaughnessy KM, Weissberg PL, Vermeer C, Shanahan CM. A polymorphism of the human matrix gamma-carboxyglutamic acid protein promoter alters binding of an activating protein-1 complex and is associated with altered transcription and serum levels. J Biol Chem. 2001;276:32466-32473.
13. Taylor BC, Schreiner PJ, Doherty TM, Fornage M, Carr JJ, Sidney S. Matrix Gla protein and osteopontin genetic associations with coronary artery calcification and bone density: the CARDIA study. Hum Genet. 2005;116:525-528.
14. O'Donnell CJ, Kavousi M, Smith AV, et al; CARDIoGRAM Consortium. Genome-wide association study for coronary artery calcification with follow-up in myocardial infarction. Circulation. 2011;124:2855-2864.
15. Herrmann SM, Whatling C, Brand E, Nicaud V, Gariepy J, Simon A, Evans A, Ruidavets JB, Arveiler D, Luc G, Tiret L, Henney A, Cambien F. Polymorphisms of the human matrix gla protein (MGP) gene, vascular calcification, and myocardial infarction. Arterioscler Thromb Vasc Biol. 2000;20:2386-2393.
16. Hale JE, Williamson MK, Price PA. Carboxyl-terminal proteolytic processing of matrix Gla protein. J Biol Chem. 1991;266:21145-21149.
17. Proudfoot D, Shanahan CM. Molecular mechanisms mediating vascular calcification: role of matrix Gla protein. Nephrology (Carlton). 2006;11:455-461.
18. Karsli Ceppio?lu S, Yurdun T, Canbakan M. Assessment of matrix Gla protein, Klotho gene polymorphisms, and oxidative stress in chronic kidney disease. Ren Fail. 2011;33:866-874.
19. Gao B, Yasui T, Itoh Y, Tozawa K, Hayashi Y, Kohri K. A polymorphism of matrix Gla protein gene is associated with kidney stones. J Urol. 2007;177:2361-2365.
20. Roy SK, Cespedes A, Li D, Choi TY, Budoff MJ. Mild and moderate pre-dialysis chronic kidney disease is associated with increased coronary artery calcium. Vasc Health Risk Manag. 2011;7:719-724.
21. Reiner AP, Kahn A, Eisner BH, Pletcher MJ, Sadetsky N, Williams OD, Polak JF, Jacobs DR Jr, Stoller ML. Kidney stones and subclinical atherosclerosis in young adults: the CARDIA study. J Urol. 2011;185:920-925.
22. Rule AD, Roger VL, Melton LJ III, Bergstralh EJ, Li X, Peyser PA, Krambeck AE, Lieske JC. Kidney stones associate with increased risk for myocardial infarction. J Am Soc Nephrol. 2010;21:1641-1644.
23. Debella YT, Giduma HD, Light RP, Agarwal R. Chronic kidney disease as a coronary disease equivalent-a comparison with diabetes over a decade. Clin J Am Soc Nephrol. 2011;6:1385-1392.
24. Turner ST, Weidman WH, Michels VV, Reed TJ, Ormson CL, Fuller T, Sing CF. Distribution of sodium-lithium countertransport and blood pressure in Caucasians five to eighty-nine years of age. Hypertension. 1989;13:378-391.
25. Kottke BA, Moll PP, Michels VV, Weidman WH. Levels of lipids, lipoproteins, and apolipoproteins in a defined population. Mayo Clin Proc. 1991;66:1198-1208.
26. Maher JE, Raz JA, Bielak LF, Sheedy PF II, Schwartz RS, Peyser PA. Potential of quantity of coronary artery calcification to identify new risk factors for asymptomatic atherosclerosis. Am J Epidemiol. 1996;144:943-953.
27. Bielak LF, Sheedy PF II, Peyser PA. Coronary artery calcification measured at electron-beam CT: agreement in dual scan runs and change over time. Radiology. 2001;218:224-229.
28. Expert Panel on Detection, Evaluation, And Treatment of High Blood Cholesterol In Adults. Executive Summary of The Third Report of The National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, And Treatment of High Blood Cholesterol In Adults (Adult Treatment Panel III). JAMA. 2001;285:2486-2497.
29. Cassidy AE, Bielak LF, Zhou Y, Sheedy PF II, Turner ST, Breen JF, Araoz PA, Kullo IJ, Lin X, Peyser PA. Progression of subclinical coronary atherosclerosis: does obesity make a difference? Circulation. 2005;111:1877-1882.
30. McCollough CH, Kaufmann RB, Cameron BM, Katz DJ, Sheedy PF II, Peyser PA. Electron-beam CT: use of a calibration phantom to reduce variability in calcium quantitation. Radiology. 1995;196:159-165.
31. Reed JE, Rumberger JA, Davitt PJ, Kaufmann RB, Sheedy PF II. System for quantitative analysis of coronary calcification via electron beam computed tomography. In: Hoffman EA, Acharya RS, eds. Medical imaging, 1994: physiology and function from multidimensional images. Bellingham, Washington: International Society for Optical Engineering, 1994; 43-53.
32. O'Meara JG, Kardia SL, Armon JJ, Brown CA, Boerwinkle E, Turner ST. Ethnic and sex differences in the prevalence, treatment, and control of dyslipidemia among hypertensive adults in the GENOA study. Arch Intern Med. 2004;164:1313-1318.
33. Turner ST, Peyser PA, Kardia SL, Bielak LF, Sheedy PF III, Boerwinkle E, de Andrade M. Genomic loci with pleiotropic effects on coronary artery calcification. Atherosclerosis. 2006;185:340-346.
34. Eckel-Passow JE, Atkinson EJ, Maharjan S, Kardia SL, de Andrade M. Software comparison for evaluating genomic copy number variation for Affymetrix 6.0 SNP array platform. BMC Bioinformatics. 2011;12:220.
35. Johnson AD, Handsaker RE, Pulit SL, Nizzari MM, O'Donnell CJ, de Bakker PI. SNAP: a web-based tool for identification and annotation of proxy SNPs using HapMap. Bioinformatics. 2008;24:2938-2939.
36. Farzaneh-Far A, Proudfoot D, Weissberg PL, Shanahan CM. Matrix gla protein is regulated by a mechanism functionally related to the calciumsensing receptor. Biochem Biophys Res Commun. 2000;277:736-740.
37. Schurgers LJ, Teunissen KJ, Knapen MH, Kwaijtaal M, van Diest R, Appels A, Reutelingsperger CP, Cleutjens JP, Vermeer C. Novel conformation-specific antibodies against matrix gamma-carboxyglutamic acid (Gla) protein: undercarboxylated matrix Gla protein as marker for vascular calcification. Arterioscler Thromb Vasc Biol. 2005;25:1629-1633.
38. Roijers RB, Debernardi N, Cleutjens JP, Schurgers LJ, Mutsaers PH, van der Vusse GJ. Microcalcifications in early intimal lesions of atherosclerotic human coronary arteries. Am J Pathol. 2011;178:2879-2887.
39. Dalmeijer GW, van der Schouw YT, Vermeer C, Magdeleyns EJ, Schurgers LJ, Beulens JW. Circulating matrix Gla protein is associated with coronary artery calcification and vitamin K status in healthy women. J Nutr Biochem. July 19, 2012. doi: 10.1016/j.jnutbio.2012.02.012.
40. Burton DG, Giles PJ, Sheerin AN, Smith SK, Lawton JJ, Ostler EL, Rhys-Williams W, Kipling D, Faragher RG. Microarray analysis of senescent vascular smooth muscle cells: a link to atherosclerosis and vascular calcification. Exp Gerontol. 2009;44:659-665.
41. O'Young J, Liao Y, Xiao Y, Jalkanen J, Lajoie G, Karttunen M, Goldberg HA, Hunter GK. Matrix Gla protein inhibits ectopic calcification by a direct interaction with hydroxyapatite crystals. J Am Chem Soc. 2011;133:18406-18412.
42. Villines TC, Hatzigeorgiou C, Feuerstein IM, O'Malley PG, Taylor AJ. Vitamin K1 intake and coronary calcification. Coronary Artery Disease. 2005;16:
43. Kronmal RA, McClelland RL, Detrano R, Shea S, Lima JA, Cushman M, Bild DE, Burke GL. Risk factors for the progression of coronary artery calcification in asymptomatic subjects: results from the Multi-Ethnic Study of Atherosclerosis (MESA). Circulation. 2007;115:2722-2730.
44. Kiechl S, Willeit J. The natural course of atherosclerosis. Part I: incidence and progression. Arterioscler Thromb Vasc Biol. 1999;19: 1484-1490.
45. Coen G, Ballanti P, Balducci A, Grandi F, Manni M, Mantella D, Pierantozzi A, Ruggeri M, Sardella D, Sorbo G, Bonucci E. Renal osteodystrophy: alpha-Heremans Schmid glycoprotein/fetuin-A, matrix GLA protein serum levels, and bone histomorphometry. Am J Kidney Dis. 2006;48:106-113.
46. Speer MY, McKee MD, Guldberg RE, Liaw L, Yang HY, Tung E, Karsenty G, Giachelli CM. Inactivation of the osteopontin gene enhances vascular calcification of matrix Gla protein-deficient mice: evidence for osteopontin as an inducible inhibitor of vascular calcification in vivo. J Exp Med. 2002;196:1047-1055.
47. Wang K, Honda H, Qureshi AR, Pecoits-Filho R, Axelsson J, Nordfors L, Schalling M, Hoff CM, Holmes CJ, Heimburger O, Stenvinkel P, Lindholm B. Association between the matrix GLA protein-7 polymorphism and carotid intima-media area and left ventricular hypertrophy in end-stage renal disease patients. ERA-EDTA XLI Congress. 2004;Lisbon, Portugal [abstract].
48. Ng PC, Henikoff S. Predicting deleterious amino acid substitutions. Genome Res. 2001;11:863-874.
49. Kumar P, Henikoff S, Ng PC. Predicting the effects of coding nonsynonymous variants on protein function using the SIFT algorithm. Nat Protoc. 2009;4:1073-1081.
50. Ramensky V, Bork P, Sunyaev S. Human non-synonymous SNPs: server and survey. Nucleic Acids Res. 2002;30:3894-3900.
51. DeFilippis AP, Blaha MJ, Ndumele CE, Budoff MJ, Lloyd-Jones DM, McClelland RL, Lakoski SG, Cushman M, Wong ND, Blumenthal RS, Lima J, Nasir K. The association of Framingham and Reynolds risk scores with incidence and progression of coronary artery calcification in MESA (Multi-Ethnic Study of Atherosclerosis). J Am Coll Cardiol. 2011;58:2076-2083.
52. Reference SNP (Ref SNP) Cluster Report: rs6488724. http://www.ncbi. nlm.nih.gov/SNP/snp-refcgi?rs=rs6488724. Accessed: March 19, 2012.
53. McClelland RL, Chung H, Detrano R, Post W, Kronmal RA. Distribution of coronary artery calcium by race, gender, and age: results from the Multi-Ethnic Study of Atherosclerosis (MESA). Circulation. 2006;113:30-37.
54. Kawakubo M, LaBree L, Xiang M, Doherty TM, Wong ND, Azen S, Detrano R. Race-ethnic differences in the extent, prevalence, and progression of coronary calcium. Ethn Dis. 2005;15:198-204.
55. Zaitlen N, Pa?aniuc B, Gur T, Ziv E, Halperin E. Leveraging genetic variability across populations for the identification of causal variants. Am J Hum Genet. 2010;86:23-33.